AMUROX

This brand name is authorized in Nigeria.

Active ingredients

The drug AMUROX contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9532	Tablet	AMUROX-500 TABLETS TAB 500 mg 1 X 10	AMUROX-500 TABLETS AMUROX CEFUROXIME AXETIL USP EQ. TO CEFUROXIME 500MG POM TABLETS 1 X 10 ANTIBIOTIC SUITELIFE PHARMACEUTICAL LTD 4 AYO DAVIES CLOSE, OFF EKOLOU STREET, SURULERE, LAGOS STATE SWISS PHARMA PVT LTD 3709, G.I.D.C PHASE IV, VATVA, AHMEDABAD- 382445, INDIA GMP- SATIS; LR- SATIS; FEES- PAID; NP: NA 09/07/2018 R R R B4-9532	30/01/2020
C4-0426	Powder for suspension	AMUROX POWDER FOR ORAL SUSPENSION PWD_F_SOL 125 mg/5 mL 1 X 60ML	36 AMUROX POWDER FOR ORAL SUSPENSION AMUROX CEFUROXIME AXETIL USP EQ. TO CEFUROXIME 125MG POM POWDER FOR ORAL SUSPENSION 1 X 60ML ANTIBIOTIC SUITELIFE PHARMACEUTICAL LTD 4 AYO DAVIES CLOSE, OFF EKOLOU STREET, SURULERE, LAGOS STATE SWISS PHARMA PVT LTD 3709, G.I.D.C PHASE IV, VATVA, AHMEDABAD- 382445, INDIA GMP- SATIS; LR- SATIS; FEES- PAID; NP: NA 17/07/2018 R R R C4-0426	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9532, C4-0426